107 related articles for article (PubMed ID: 14565615)
1. Access to antiretroviral drugs and AIDS management in Senegal.
Desclaux A; Ciss M; Taverne B; Sow PS; Egrot M; Faye MA; Lanièce I; Sylla O; Delaporte E; Ndoye I
AIDS; 2003 Jul; 17 Suppl 3():S95-101. PubMed ID: 14565615
[TBL] [Abstract][Full Text] [Related]
2. Adherence to HAART and its principal determinants in a cohort of Senegalese adults.
Lanièce I; Ciss M; Desclaux A; Diop K; Mbodj F; Ndiaye B; Sylla O; Delaporte E; Ndoye I
AIDS; 2003 Jul; 17 Suppl 3():S103-8. PubMed ID: 14565616
[TBL] [Abstract][Full Text] [Related]
3. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.
Laurent C; Diakhaté N; Gueye NF; Touré MA; Sow PS; Faye MA; Gueye M; Lanièce I; Touré Kane C; Liégeois F; Vergne L; Mboup S; Badiane S; Ndoye I; Delaporte E
AIDS; 2002 Jul; 16(10):1363-70. PubMed ID: 12131213
[TBL] [Abstract][Full Text] [Related]
4. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
Vergne L; Kane CT; Laurent C; Diakhaté N; Gueye NF; Gueye PM; Sow PS; Faye MA; Liégeois F; Ndir A; Lanièce I; Peeters M; Ndoye I; Mboup S; Delaporte E
AIDS; 2003 Jul; 17 Suppl 3():S31-8. PubMed ID: 14565607
[TBL] [Abstract][Full Text] [Related]
5. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.
Sidibé M
Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132
[No Abstract] [Full Text] [Related]
6. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
[TBL] [Abstract][Full Text] [Related]
7. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.
Greco DB; Simão M
AIDS; 2007 Jul; 21 Suppl 4():S37-45. PubMed ID: 17620751
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.
Bautista-Arredondo S; Mane A; Bertozzi SM
AIDS; 2006 Jan; 20(1):101-9. PubMed ID: 16327325
[TBL] [Abstract][Full Text] [Related]
9. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
Attaran A; Gillespie-White L
JAMA; 2001 Oct; 286(15):1886-92. PubMed ID: 11597292
[TBL] [Abstract][Full Text] [Related]
10. HAART in India.
John BV; Thomas S
Lancet; 2004 Feb; 363(9407):493. PubMed ID: 14962542
[No Abstract] [Full Text] [Related]
11. [Drugs for antiretroviral therapy. The costs of HAART].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
[No Abstract] [Full Text] [Related]
12. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
[TBL] [Abstract][Full Text] [Related]
13. Access to antiretroviral treatment in Latin American countries and the Caribbean.
Chequer P; Cuchí P; Mazin R; García Calleja JM
AIDS; 2002 Dec; 16 Suppl 3():S50-7. PubMed ID: 12685925
[TBL] [Abstract][Full Text] [Related]
14. The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand.
Chasombat S; Lertpiriyasuwat C; Thanprasertsuk S; Suebsaeng L; Lo YR
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):704-15. PubMed ID: 17121296
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment in resource-poor settings: the Brazilian experience.
Teixeira PR; Vitória MA; Barcarolo J
AIDS; 2004 Jun; 18 Suppl 3():S5-7. PubMed ID: 15322477
[TBL] [Abstract][Full Text] [Related]
16. Prioritising access to antiretroviral therapy in resource-poor settings.
Lange JM; van der Waals FW
J HIV Ther; 2002 Aug; 7(3):59-62. PubMed ID: 12442166
[TBL] [Abstract][Full Text] [Related]
17. Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Côte d'Ivoire.
Msellati P; Juillet-Amari A; Prudhomme J; Akribi HA; Coulibaly-Traore D; Souville M; Moatti JP;
AIDS; 2003 Jul; 17 Suppl 3():S63-8. PubMed ID: 14565611
[TBL] [Abstract][Full Text] [Related]
18. [Free dispensing of antiretroviral treatments in Africa].
Taverne B
Bull Soc Pathol Exot; 2003 Aug; 96(3):241-4. PubMed ID: 14582303
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.
Djobet MP; Singhe D; Lohoue J; Kuaban C; Ngogang J; Tambo E
AIDS Res Ther; 2017 Apr; 14(1):19. PubMed ID: 28376825
[TBL] [Abstract][Full Text] [Related]
20. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
